May 28, 2021

Roche Canada Announces Collaboration to Improve Access to Personalized Healthcare with Real World Evidence

BC Cancer, CPHIN and Roche Canada will co-create an evidence-generating framework to leverage real-world data and facilitate cost-effective access to targeted treatments for cancer patients

Hoffmann-La Roche Limited (Roche Canada) is pleased to announce a joint initiative with BC Cancer and the Canadian Personalized Healthcare Innovation Network (CPHIN) to co-create a real-world evidence (RWE) framework in British Columbia known as the PRecision Oncology Evidence Development in Cancer Treatment (PREDiCT).
Sep 21, 2020

Drs. Maryam Darvishian and Parveen Bhatti published in Journal of Medical Virology on the association between markers of immune response at hospital admission and COVID‐19 disease severity and mortality

Congratulations to Drs. Maryam Darvishian and Parveen Bhatti of Cancer Control Research for having their paper entitled “Association between markers of immune response at hospital admission and COVID‐19 disease severity and mortality: A meta‐analysis and meta‐regression” accepted by the Journal of Medical Virology.
Sep 04, 2020

BC Generations Project, part of the Canadian Partnership for Tomorrow's Health (CanPATH), awarded $1.75M to support efforts in the assessment of COVID-19 seroprevalence

BC Generations Project, part of the Canadian Partnership for Tomorrow's Health (CanPATH) has been awarded for $1.75 million by the COVID-19 Immunity Task Force.
Jul 02, 2020

BC Generations Project proud to be part of SUPPORT-Canada – a new Canadian Population Cohort COVID-19 Initiative

The BC Generations Project with Dr. Parveen Bhatti through the Canadian Partnership for Tomorrow’s Health with $2.1 million in new funding awarded by CIHR are proud to be part of a new Canadian Population Cohort COVID-19 Initiative, SUrveilling Prospective Population cOhorts for COVID19 pRevalence and ouTcomes in Canada (SUPPORT-Canada).
Back to top